Gilead's COVID-19 drug Veklury brought in almost $2bn in Q4

Retrieved on: 2021-02-05 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Gilead's COVID-19 drug Veklury brought in almost $2bn in Q4. View article details on hiswai:

Excerpt

Gilead's COVID-19 antiviral drug Veklury, also known as remdesivir, brought in close to $2bn in sales in the company's fourth quarter results.

Article found on: www.pmlive.com